Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Warner Bros
WBD
|
+$130M |
| 2 |
Tesla
TSLA
|
+$76.4M |
| 3 |
Roblox
RBLX
|
+$50.1M |
| 4 |
VICI Properties
VICI
|
+$43.2M |
| 5 |
Danaher
DHR
|
+$41.2M |
Top Sells
| 1 |
AT&T
T
|
+$209M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$91.9M |
| 4 |
Canadian National Railway
CNI
|
+$53.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.5M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
1726
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.64M | ﹤0.01% |
112,100
| – | – |
|
1727
NovaGold Resources
NG
$2.82B
| $2.64M | ﹤0.01% |
552,500
| – | – |
|
1728
Marten Transport
MRTN
$953M
| $2.63M | ﹤0.01% |
156,475
+9,400
| +6% | +$158K |
|
1729
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2.62M | ﹤0.01% |
260,600
| – | – |
|
1730
Live Oak Bancshares
LOB
$1.67B
| $2.62M | ﹤0.01% |
77,200
+700
| +0.9% | +$23.7K |
|
1731
Agilysys
AGYS
$2.97B
| $2.61M | ﹤0.01% |
55,300
| – | – |
|
1732
Clearway Energy Class A
CWEN.A
$3.21B
| $2.61M | ﹤0.01% |
81,550
+3,800
| +5% | +$121K |
|
1733
Malibu Boats
MBUU
$629M
| $2.6M | ﹤0.01% |
49,300
| – | – |
|
1734
Gates Industrial
GTES
$6.6B
| $2.6M | ﹤0.01% |
240,300
+102,300
| +74% | +$1.11M |
|
1735
Hayward Holdings
HAYW
$3.38B
| $2.59M | ﹤0.01% |
180,100
+70,400
| +64% | +$1.01M |
|
|
EVBG
1736
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.59M | ﹤0.01% |
92,900
+1,800
| +2% | +$50.2K |
|
1737
CTS Corp
CTS
$1.23B
| $2.58M | ﹤0.01% |
75,900
+7,300
| +11% | +$249K |
|
1738
Open Lending Corp
LPRO
$252M
| $2.58M | ﹤0.01% |
252,550
+43,700
| +21% | +$447K |
|
1739
Asana
ASAN
$3.12B
| $2.58M | ﹤0.01% |
146,600
-141,900
| -49% | -$2.49M |
|
1740
Frontline
FRO
$5.17B
| $2.57M | ﹤0.01% |
289,743
+54,457
| +23% | +$484K |
|
1741
Nabors Industries
NBR
$617M
| $2.57M | ﹤0.01% |
19,200
+1,700
| +10% | +$228K |
|
1742
SpartanNash
SPTN
$897M
| $2.56M | ﹤0.01% |
84,980
| – | – |
|
1743
Relay Therapeutics
RLAY
$688M
| $2.56M | ﹤0.01% |
153,000
+50,800
| +50% | +$851K |
|
1744
Agios Pharmaceuticals
AGIO
$2.14B
| $2.56M | ﹤0.01% |
115,560
| – | – |
|
1745
DNOW Inc
DNOW
$1.6B
| $2.56M | ﹤0.01% |
261,400
| – | – |
|
1746
Axsome Therapeutics
AXSM
$5.91B
| $2.55M | ﹤0.01% |
66,600
+8,600
| +15% | +$329K |
|
1747
S&T Bancorp
STBA
$1.5B
| $2.55M | ﹤0.01% |
93,000
| – | – |
|
|
KNBE
1748
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $2.55M | ﹤0.01% |
163,100
+87,200
| +115% | +$1.36M |
|
1749
Arcus Biosciences
RCUS
$1.23B
| $2.55M | ﹤0.01% |
100,496
+9,200
| +10% | +$233K |
|
|
MAG
1750
DELISTED
MAG Silver
MAG
| $2.55M | ﹤0.01% |
208,900
+5,300
| +3% | +$64.6K |
|